North American Scientific's multi-probe ultrasound IGRT IGRT (image-guided radiation therapy):
This article was originally published in Clinica
Executive Summary
North American Scientific (NAS) has received US FDA 510(k) clearance to market its Batcam multi-probe ultrasound image-guided radiation therapy (IGRT) system. The product features an updated colour Doppler abdominal ultrasound probe that enables IGRT for the liver, pancreas, prostate and for gynaecology conditions. Optional add-ons to the system include a biplanar rectal probe for prostate volume studies and prostate brachytherapy, and a wideband, linear probe for verifying accelerated partial breast irradiation brachytherapy devices. Batcam multi-probe is expected to be available for shipment early this month.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.